A detailed history of Profund Advisors LLC transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 23,516 shares of MDXG stock, worth $213,995. This represents 0.01% of its overall portfolio holdings.

Number of Shares
23,516
Previous 26,895 12.56%
Holding current value
$213,995
Previous $186,000 25.81%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$5.65 - $7.76 $19,091 - $26,221
-3,379 Reduced 12.56%
23,516 $138,000
Q2 2024

Aug 13, 2024

SELL
$6.16 - $8.08 $118,807 - $155,838
-19,287 Reduced 41.76%
26,895 $186,000
Q1 2024

May 08, 2024

BUY
$7.61 - $8.63 $111,943 - $126,947
14,710 Added 46.74%
46,182 $355,000
Q4 2023

Feb 14, 2024

SELL
$5.7 - $9.14 $44,670 - $71,630
-7,837 Reduced 19.94%
31,472 $276,000
Q3 2023

Nov 13, 2023

BUY
$6.35 - $8.16 $83,737 - $107,605
13,187 Added 50.48%
39,309 $286,000
Q2 2023

Aug 10, 2023

SELL
$3.14 - $6.61 $22,780 - $47,955
-7,255 Reduced 21.74%
26,122 $172,000
Q1 2023

May 11, 2023

BUY
$2.97 - $4.81 $99,129 - $160,543
33,377 New
33,377 $113,000
Q4 2018

Feb 14, 2019

SELL
$1.15 - $6.45 $24,181 - $135,624
-21,027 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$3.22 - $6.33 $9,106 - $17,901
-2,828 Reduced 11.85%
21,027 $130,000
Q2 2018

Aug 13, 2018

BUY
$5.39 - $8.96 $17,776 - $29,550
3,298 Added 16.04%
23,855 $152,000
Q1 2018

May 14, 2018

BUY
$6.69 - $17.96 $36,380 - $97,666
5,438 Added 35.97%
20,557 $143,000
Q4 2017

Feb 14, 2018

BUY
$10.87 - $13.9 $20,294 - $25,951
1,867 Added 14.09%
15,119 $191,000
Q3 2017

Nov 13, 2017

SELL
$11.86 - $17.34 $71,919 - $105,149
-6,064 Reduced 31.39%
13,252 $157,000
Q2 2017

Aug 11, 2017

BUY
N/A
19,316
19,316 $289,000

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $1.03B
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.